Items where authors include "Mitlak, B.H."

Article

Eastell, R. orcid.org/0000-0002-0323-3366, Brown, J.P. orcid.org/0000-0003-1910-788X, Adler, R.A. et al. (6 more authors) (2025) Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) study. Journal of Bone and Mineral Research, 40 (3). pp. 315-322. ISSN 0884-0431

Eastell, R. orcid.org/0000-0002-0323-3366, Mitlak, B.H., Wang, Y. et al. (3 more authors) (2019) Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporosis International, 30 (3). pp. 667-673. ISSN 0937-941X

Reginster, J.-Y., Cooper, C., Rizzoli, R. et al. (20 more authors) (2016) Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clinical and Experimental Research, 28 (1). pp. 47-58. ISSN 1594-0667

Proceedings Paper

Brown, J.P., Adler, R.A., Lewiecki, E.M. et al. (6 more authors) (2024) 6733 Bone turnover markers predict bone mineral density increases with abaloparatide in men similarly to women: results from ATOM. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .